SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001206774-09-001620
Filing Date
2009-08-25
Accepted
2009-08-25 06:03:24
Documents
7
Period of Report
2009-08-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT avigen_8k.htm 8-K 24839
2 AGREEMENT AND PLAN OF MERGER, DATED AUGUST 20, 2008 exhibit2-1.htm EX-2.1 459933
3 AMENDMENT TO RIGHTS AGREEMENT, DATED AUGUST 20, 2008 exhibit4-1.htm EX-4.1 22922
4 AMENDMENT TO MANAGEMENT TRANSITION PLAN, EFFECTIVE AS OF AUGUST 20, 2009 exhibit10-1.htm EX-10.1 3350
5 JOINT PRESS RELEASE OF AVIGEN AND MEDICINOVA, DATED AUGUST 21, 2009 exhibit99-1.htm EX-99.1 14473
6 GRAPHIC exhibit99-1x1x1.jpg GRAPHIC 15328
7 GRAPHIC exhibit99-1x1x2.jpg GRAPHIC 6336
  Complete submission text file 0001206774-09-001620.txt   557264
Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Filer) CIK: 0000932903 (see all company filings)

IRS No.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1121
Type: 8-K | Act: 34 | File No.: 000-28272 | Film No.: 091032692
SIC: 2835 In Vitro & In Vivo Diagnostic Substances